Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
5.61x2.18x0.02x2.45x3.64x3.7x3.32% 805.78Cr
19.27x2.24x-3.16x4.38x13.18x13.5x0.51% 7.7TCr
28.81x4.07x2.46x5.76x16.65x20.94x0.55% 5.93TCr
38.99x7.96x0.72x13.14x24.04x28.59x-.--% 5.07TCr
35.5x2.45x-0.65x3.56x10.3x11.69x2.99% 4.73TCr
14.9x1.29x0.42x2.82x8.42x9.2x-.--% 2.6TCr
-7.42x3.36x28.16x8.35x-6.15x-5.85x-.--% 2.13TCr
15.76x2.91x-4.98x2.56x8.07x7.63x-.--% 1.95TCr
24.95x3.5x0.02x5.05x13.75x18.35x-.--% 1.59TCr
-39.37x-6.32x0.81x17.75x-49.52x-58.41x-.--% 1.49TCr
73.44x29.08x0.84x37.78x51.34x52.31x0.1% 1.34TCr
12.71x - 0.09x3.03x13.19x19.7x-.--% 1.05TCr
-215.49x60.95x2.83x9.65x223.94x-221.97x-.--% 966.75Cr
35.12x - 2.48x - - - -.--% 807.16Cr
82.46x5.83x-1.06x - - - - 777.58Cr
-219.36x - 0.67x - - - -.--% 735.61Cr
12.09x1.09x0.34x1.84x7.35x9.73x2% 706.82Cr
34.84x - 0.44x9.02x26.99x33.23x0.28% 568.84Cr
20.36x1.09x1.22x - - - 1.58% 548.24Cr
Average -1.41x 8.11x 1.67x 8.48x 24.35x -3.84x 0.63% 2.18TCr
Weighted average by Cap. 14.42x 5.51x 1.21x 7.44x 17.25x 7.82x 0.65%
Biopharmaceuticals